Bronchopulmonary Dysplasia and Innate Immunity: A Narrative Review of the Roles of IL-1β and IL-8 (CXCL8)

Dubravka Bačaj Ivanić1, Štefan Grosek2,3, Andreja Nataša Kopitar4

  • 1Department of Gynecology and Obstetrics, Clinical Hospital Sveti Duh, 10000 Zagreb, Croatia.

Insights

Elevated levels of interleukin-1β (IL-1β) and interleukin-8 (IL-8/CXCL8) are linked to bronchopulmonary dysplasia (BPD) in premature infants. These inflammatory markers play a key role in the development of this chronic lung disease.

Area of Science:

  • Neonatal immunology
  • Pulmonology
  • Inflammatory diseases

Background:

  • Bronchopulmonary dysplasia (BPD) is a significant chronic lung disease in extremely premature newborns.
  • Both prenatal and postnatal factors, alongside innate immune system activation, contribute to BPD etiology.
  • Interleukin-1β (IL-1β) and IL-8 (CXCL8) are key bioactive mediators in the inflammatory response.

Purpose of the Study:

  • To review the role of the innate immune system in BPD development.
  • To synthesize evidence on IL-1β and IL-8 (CXCL8) in BPD from human and animal studies.
  • To explore the interaction between IL-1β and IL-8 (CXCL8) in chronic lung disease pathogenesis.

Main Methods:

  • A comprehensive literature search was performed across major biomedical databases (PubMed, Scopus, Web of Science, Ovid MEDLINE).
  • Studies published between 1993 and November 2025 were included.
  • Evidence from human and animal studies was synthesized narratively.

Main Results:

  • The review details the innate immune system's mechanisms in initiating inflammation in BPD.
  • Evidence from human and animal models links IL-1β and IL-8 (CXCL8) to BPD.
  • The interplay between IL-1β and IL-8 (CXCL8) in chronic lung disease development is described.

Conclusions:

  • Human and animal studies indicate a strong association between elevated IL-1β and IL-8 (CXCL8) levels and BPD.
  • These cytokines are implicated as significant contributors to the pathogenesis of BPD in premature infants.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...